Levels erythrocyte and plasma magnesium in patients in chronic dialysis
García-Ortiz, R.; Milovic, I.; Uribe, C.; Gómez, M.
Revista Medica de Chile 117(5): 544-548
1989
ISSN/ISBN: 0034-9887 PMID: 2519814 Document Number: 346865
Document emailed within 1 workday
Related Documents
García-Ortiz, R.; Milovic, I.; Uribe, C.; Gómez, M. 1989: Levels erythrocyte and plasma magnesium in patients in chronic dialysis Revista Medica de Chile 117(5): 544-548Selivonenko, V.G.; Piasetskiĭ, I.S. 1971: Plasma and erythrocyte levels of calcium and magnesium in patients at various stages of hypertensive disease Sovetskaia Meditsina 34(5): 140-142
Obrzut, D. 1972: Hypoxemia and serum and erythrocyte magnesium levels in patients with chronic respiratory diseases Polski Tygodnik Lekarski 27(27): 1041-1044
Allegra, A.; Corica, F.; Ientile, R.; Corsonello, A.; Sparacino, V.; Accettola, F.; Caputo, F.; Macaione, S.; Buemi, M. 1998: Plasma (total and ionized), erythrocyte and platelet magnesium levels in renal transplant recipients during cyclosporine and/or azathioprine treatment Magnesium Research 11(1): 11-18
Kooman, J.P.; Schalkwijk, C.G.; Konings, C.J. 2006: The increase in plasma levels of Nepsilon-(carboxymethyl)lysine during icodextrin treatment of peritoneal dialysis patients is not associated with increased plasma levels of vascular cell adhesion molecule-1 Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 26(3): 410-411
Hory, B.; Henriet, M.T. 1983: Variations in blood aldosterone, plasma renin activity and plasma levels of converting enzyme during bicarbonate dialysis in chronic kidney failure Nephrologie 4(4-5): 229-230
Szczepańska, M.; Szprynger, K.; Mazur, B.; Zwolińska, D.; Kiliś-Pstrusińska, K.; Makulska, I. 2007: Plasma ghrelin levels in children with chronic renal failure on peritoneal dialysis Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 27(1): 61-66
Pietrzak, I.; Bladek, K.; Bulikowski, W. 2002: Comparison of magnesium and zinc levels in blood in end stage renal disease patients treated by hemodialysis or peritoneal dialysis Magnesium Research 15(3-4): 229-236
Matera, S.; Majewska, G.; Krzyzaniak, J. 1983: Plasma copper, zinc and magnesium levels in patients with primary lung cancer Pneumonologia Polska 51(8-9): 475-480
Buemi, M.; Corica, F.; Squadrito, F.; Ceruso, D.; Frisina, N. 1988: Plasma and erythrocyte magnesium concentrations in essential arterial hypertension Kidney International. Suppl 25: S14-S15
Romanova, L.A.; Lugovskaia, S.A.; Shutov, E.V.; Shmarov, D.A.; Korovina, V.I.; Gorodnicheva, V.F.; Kozinets, G.I. 2001: Evaluation of changes in erythrocyte functions and iron metabolism in patients with chronic renal failure treated by peritoneal dialysis Klinicheskaia Laboratornaia Diagnostika 6: 24; 33-36
Taralov, Z.; Koumtchev, E.; Lyutakova, Z. 1998: Erythrocyte ferritin levels in chronic renal failure patients Folia Medica 40(4): 65-70
Hutchison, A.J.; Merchant, M.; Boulton, H.F.; Hinchcliffe, R.; Gokal, R. 1993: Calcium and magnesium mass transfer in peritoneal dialysis patients using 1.25 mmol/L calcium, 0.25 mmol/L magnesium dialysis fluid Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 13(3): 219-223
Putadechakum, S.; Tanphaichitr, V.; Leelahagul, P.; Pakpeankitvatana, V.; Surapisitchart, T.; Komindr, S. 2005: Long-term treatment of N-3 PUFAS on plasma lipoprotein levels and fatty acid composition of total serum and erythrocyte lipids in hypertriglyceridemic patients Journal of the Medical Association of Thailand 88(2): 181-186
Martínez, M.E.; Miguel, J.L.; Gómez, P.; Selgas, R.; Salinas, M.; Gentil, M.; Mateos, F.; Montero, J.L.; Sánchez Sicilia, L. 1983: Plasma calcitonin concentration in patients treated with chronic dialysis: differences between hemodialysis and CAPD Clinical Nephrology 19(5): 250-253
Panichi, V.; Taccola, D.; Rizza, G.Manca.; Consani, C.; Migliori, M.; Filippi, C.; Paoletti, S.; Sidoti, A.; Borracelli, D.; Panicucci, E.; Giovannini, L. 2004: Ceruloplasmin and acute phase protein levels are associated with cardiovascular disease in chronic dialysis patients Journal of Nephrology 17(5): 715-720
Guideri, G. 1992: Catecholamine modulation of magnesium plasma levels in the rat Archives Internationales de Pharmacodynamie et de Therapie 320: 103-114
Gallacher, R.E.; Browning, M.C.; Fraser, C.G.; Wilkinson, S.P.; MacLennan, W.J. 1987: A method for simultaneously estimating plasma, erythrocyte, and leukocyte sodium, potassium, and magnesium: reference values and considerations from biological variation data Clinical Chemistry 33(8): 1326-1330
Oral, I.; Stejskal, D.; Loucký, J.; Sislák, Z.; Coufal, Z.; Mistrík, J.; Náplava, R. 2004: Impact of acute fluid restriction on levels of natriuretic peptides in patients on a chronic dialysis program Vnitrni Lekarstvi 50(11): 812-817
Baron, M.; Levitt, M.; Asnis, L.; Fein, M. 1983: Prolactin levels in schizophrenia: relation to platelet monoamine oxidase, plasma amine oxidase, plasma dopamine-beta-hydroxylase, and erythrocyte catechol-O-methyltransferase activity Biological Psychiatry 18(5): 579-582